IBJNews

Endocyte raises another $100M in stock offering

Back to TopCommentsE-mailPrintBookmark and Share

Endocyte Inc. raised $101.8 million in a public stock offering, the West Lafayette-based drugmaker announced last week, giving it more cash to keep developing its stable of cancer drugs.

The biotech drug firm said in December it would sell up to $60 million in stock “from time to time". But Endocyte was able to raise far more because its stock shot up March 21 after its first drug, Vynfinit, passed a critical hurdle to get onto the market in Europe and the drug showed promise in a trial of lung cancer patients.

Those announcements even sparked talk of Endocyte being acquired by a large pharmaceutical company.

“This could be a machine that produces multiple drugs,” Simos Simeonidis, a New York-based analyst at Cowen, told Bloomberg News. “I think definitely big pharma or big biotech would be interested in bringing this in house.”

Even so, investors were disappointed by the price of Endocyte’s public offering of $21 per share. The price was announced after markets closed March 25, when Endocyte shares closed at $27.19 apiece. They fell more than 19 percent the rest of the week.

The additional funds now mean Endocyte has $225 million to perform clinical trials and other R&D work on its drugs, as well as to build the commercial team it needs to launch its drug in Europe.

In 2013, Endocyte burned through $83 million on R&D and administrative costs, although more than $20 million of that bill was paid by New Jersey-based Merck & Co. Inc., which has licensed the rights to Vynfinit.

Merck will handle sales and marketing of Vynfinit, if the drug receives final approval from the European Union. But Endocyte will handle sales of a companion diagnostic agent called Folcepri, which is key for identifying patients who will benefit from Vynfinit.

Endocyte’s technology was first developed at Purdue University by chemist Philip Low. Since some cancer tumors have an abundance of “receptors” that bind easily with the vitamin folate, Low figured a powerful chemotherapy drug could be combined with a folate molecule so it would target only cancerous cells and not healthy cells.

That allows Endocyte’s drugs to be more deadly to cancer without more serious side effects than patients can tolerate with traditional chemotherapy agents. The company is also developing drugs to treat other diseases, such as inflammation.

Endocyte, founded in 1995, went public in 2011, raising $145 million in two public stock offerings.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Of what value is selling alcoholic beverages to State Fair patrons when there are many families with children attending. Is this the message we want to give children attending and participating in the Fair, another venue with alooholic consumption onsite. Is this to promote beer and wine production in the state which are great for the breweries and wineries, but where does this end up 10-15 years from now, lots more drinkers for the alcoholic contents. If these drinks are so important, why not remove the alcohol content and the flavor and drink itself similar to soft drinks would be the novelty, not the alcoholic content and its affects on the drinker. There is no social or material benefit from drinking alcoholic beverages, mostly people want to get slightly or highly drunk.

  2. I did;nt know anyone in Indiana could count- WHY did they NOT SAY just HOW this would be enforced? Because it WON;T! NOW- with that said- BIG BROTHER is ALIVE in this Article-why take any comment if it won't appease YOU PEOPLE- that's NOT American- with EVERYTHING you indicated is NOT said-I can see WHY it say's o Comments- YOU are COMMIES- BIG BROTHER and most likely- voted for Obama!

  3. In Europe there are schools for hairdressing but you don't get a license afterwards but you are required to assist in turkey and Italy its 7 years in japan it's 10 years England 2 so these people who assist know how to do hair their not just anybody and if your an owner and you hire someone with no experience then ur an idiot I've known stylist from different countries with no license but they are professional clean and safe they have no license but they have experience a license doesn't mean anything look at all the bad hairdressers in the world that have fried peoples hair okay but they have a license doesn't make them a professional at their job I think they should get rid of it because stateboard robs stylist and owners and they fine you for the dumbest f***ing things oh ur license isn't displayed 100$ oh ur wearing open toe shoes fine, oh there's ONE HAIR IN UR BRUSH that's a fine it's like really? So I think they need to go or ease up on their regulations because their too strict

  4. Exciting times in Carmel.

  5. Twenty years ago when we moved to Indy I was a stay at home mom and knew not very many people.WIBC was my family and friends for the most part. It was informative, civil, and humerous with Dave the KING. Terri, Jeff, Stever, Big Joe, Matt, Pat and Crumie. I loved them all, and they seemed to love each other. I didn't mind Greg Garrison, but I was not a Rush fan. NOW I can't stand Chicks and all their giggly opinions. Tony Katz is to abrasive that early in the morning(or really any time). I will tune in on Saturday morning for the usual fun and priceless information from Pat and Crumie, mornings it will be 90.1

ADVERTISEMENT